Literature DB >> 3120199

Abnormal gait sequence in locomotion after atropine treatment of catecholamine-deficient akinetic rats.

S M Pellis1, V C Pellis, R M Chesire, N Rowland, P Teitelbaum.   

Abstract

Excessive, abnormal locomotion occurs after a high dose (25-50 mg/kg) of atropine sulfate to rats already akinetic due to catecholamine deficiency from intraventricular administration of 6-hydroxydopamine. This abnormal locomotion involves an abnormal gait sequence [right (R) hindleg (H), left (L) foreleg (F), LH, RF] instead of the normal gait sequence (RH, RF, LH, LF). In such animals atropine progressively (i) decreases hindleg step size, (ii) decreases arching of the trunk, and (iii) increases foreleg step size. These factors combine to change the ratio of front/hind body support. If the body stretches too far and the hindleg step is too small, a given hindleg step supports insufficient weight to remove weight from the ipsilateral foreleg; consequently, the opposite foreleg must execute the next step, producing the abnormal gait sequence. Thus, atropine affects gait sequence indirectly; it acts on at least three variables that affect how body weight is distributed and shifted during locomotion. To maintain stability during such locomotion, gait sequence is appropriately altered.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120199      PMCID: PMC299624          DOI: 10.1073/pnas.84.23.8750

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  Locomotion in vertebrates: central mechanisms and reflex interaction.

Authors:  S Grillner
Journal:  Physiol Rev       Date:  1975-04       Impact factor: 37.312

2.  6-hydroxydopamine and anticholinergic drugs.

Authors:  T Schallert; I Q Whishaw; V D Ramirez; P Teitelbaum
Journal:  Science       Date:  1978-12-15       Impact factor: 47.728

3.  Compulsive, abnormal walking caused by anticholinergics in akinetic, 6-hydroxydopamine-treated rats.

Authors:  T Schallert; I Q Whishaw; V D Ramirez; P Teitelbaum
Journal:  Science       Date:  1978-03-31       Impact factor: 47.728

4.  The postures of catecholamine-depletion catalepsy: their possible adaptive value in thermoregulation.

Authors:  T Schallert; I Q Whishaw; M De Ryck; P Teitelbaum
Journal:  Physiol Behav       Date:  1978-11

5.  Interaction between central and peripheral mechanisms in the control of locomotion.

Authors:  S Grillner
Journal:  Prog Brain Res       Date:  1979       Impact factor: 2.453

6.  Quantitative aspects of normal locomotion in rats.

Authors:  R E Hruska; S Kennedy; E K Silbergeld
Journal:  Life Sci       Date:  1979-07-09       Impact factor: 5.037

7.  Abnormal locomotion in rats after bilateral intrastriatal injection of kainic acid.

Authors:  R E Hruska; E K Silbergeld
Journal:  Life Sci       Date:  1979-07-09       Impact factor: 5.037

8.  Intraventricular anti-cholinergics do not block cholinergic hippocampal RSA or neocortical desynchronization in the rabbit or rat.

Authors:  I Q Whishaw; T E Robinson; T Schallert
Journal:  Pharmacol Biochem Behav       Date:  1976-09       Impact factor: 3.533

9.  The lateral hypothalamic syndrome: recovery of feeding and drinking after lateral hypothalamic lesions.

Authors:  P TEITELBAUM; A N EPSTEIN
Journal:  Psychol Rev       Date:  1962-03       Impact factor: 8.934

10.  Effects of dietary protein and tyrosine on behavior of diabetic rats.

Authors:  L L Bellush; N E Rowland
Journal:  Am J Physiol       Date:  1986-08
View more
  2 in total

1.  Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian's Disease.

Authors:  Ji Yong Lee; Hyun Soo Kim; Sung Hoon Kim; Han-Soo Kim; Byung Pil Cho
Journal:  Tissue Eng Regen Med       Date:  2020-01-22       Impact factor: 4.169

2.  Multifactorial motor behavior assessment for real-time evaluation of emerging therapeutics to treat neurologic impairments.

Authors:  Riazul Islam; Carlos A Cuellar; Ben Felmlee; Tori Riccelli; Jodi Silvernail; Suelen Lucio Boschen; Peter Grahn; Igor Lavrov
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.